Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Penumbra, Inc. (PEN : NYSE)
 
 • Company Description   
Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California.

Number of Employees: 3,800

 
 • Price / Volume Information   
Yesterday's Closing Price: $143.25 Daily Weekly Monthly
20 Day Moving Average: 350,069 shares
Shares Outstanding: 37.68 (millions)
Market Capitalization: $5,397.32 (millions)
Beta: 0.61
52 Week High: $293.20
52 Week Low: $130.96
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -27.56% -20.92%
12 Week -32.16% -26.68%
Year To Date -50.14% -40.94%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
One Penumbra Place
-
Alameda,CA 94502
USA		 ph: 510-748-3200
fax: 510-748-3232		 investors@penumbrainc.com http://www.penumbrainc.com
 
 • General Corporate Information   
Officers
Adam Elsesser - Chief Executive Officer;Chairman
Maggie Yuen - Chief Financial Officer
Lambert Shiu - Chief Accounting Officer
Arani Bose - Director
Don Kassing - Director

Peer Information
Penumbra, Inc. (ABMD)
Penumbra, Inc. (DMDS)
Penumbra, Inc. (CPWY.)
Penumbra, Inc. (EQUR)
Penumbra, Inc. (ECIA)
Penumbra, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 70975L107
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 37.68
Most Recent Split Date: (:1)
Beta: 0.61
Market Capitalization: $5,397.32 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.06 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.20 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 707.41
Trailing 12 Months: 341.07
PEG Ratio: -
Price Ratios
Price/Book: 5.63
Price/Cash Flow: 125.25
Price / Sales: 6.90
EPS Growth
vs. Year Ago Period: -103.70%
vs. Previous Quarter: -110.00%
Sales Growth
vs. Year Ago Period: 20.50%
vs. Previous Quarter: -0.06%
ROE
03/31/22 - 1.97
12/31/21 - 3.57
09/30/21 - 5.77
ROA
03/31/22 - 1.45
12/31/21 - 2.67
09/30/21 - 4.30
Current Ratio
03/31/22 - 5.31
12/31/21 - 5.53
09/30/21 - 5.76
Quick Ratio
03/31/22 - 3.20
12/31/21 - 3.39
09/30/21 - 3.53
Operating Margin
03/31/22 - 2.05
12/31/21 - 3.54
09/30/21 - 5.37
Net Margin
03/31/22 - -0.83
12/31/21 - 0.71
09/30/21 - 4.72
Pre-Tax Margin
03/31/22 - -3.59
12/31/21 - -1.40
09/30/21 - 4.21
Book Value
03/31/22 - 25.46
12/31/21 - 25.53
09/30/21 - 18.33
Inventory Turnover
03/31/22 - 1.11
12/31/21 - 1.07
09/30/21 - 1.09
Debt-to-Equity
03/31/22 - 0.03
12/31/21 - 0.03
09/30/21 - 0.04
Debt-to-Capital
03/31/22 - 2.65
12/31/21 - 2.71
09/30/21 - 3.76
 

Powered by Zacks Investment Research ©